Association between Pathological Complete Response and Outcome Following Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Patients

por Luangdilok, Sutima, Samarnthai, Norasate, Korphaisarn, Krittiya
Publicado 2014

Safety Following COVID-19 Booster Vaccine with BNT162b2 Compared to mRNA-1273 in Solid Cancer Patients Previously Vaccinated with ChAdOx1 or CoronaVac

por Wanchaijiraboon, Passakorn, Sainamthip, Panot, Teeyapun, Nattaya, Luangdilok, Sutima, Poovorawan, Yong, Wanlapakorn, Nasamon, Tanasanvimon, Suebpong, Sriuranpong, Virote, Susiriwatananont, Thiti, Zungsontiporn, Nicha, Pakvisal, Nussara
Publicado 2023

Immunogenicity after a Third COVID-19 mRNA Booster in Solid Cancer Patients Who Previously Received the Primary Heterologous CoronaVac/ChAdOx1 Vaccine

por Luangdilok, Sutima, Wanchaijiraboon, Passakorn, Pakvisal, Nussara, Susiriwatananont, Thiti, Zungsontiporn, Nicha, Sriuranpong, Virote, Sainamthip, Panot, Suntronwong, Nungruthai, Vichaiwattana, Preeyaporn, Wanlapakorn, Nasamon, Poovorawan, Yong, Teeyapun, Nattaya, Tanasanvimon, Suebpong
Publicado 2022

Vaccine-Related adverse events following AZD1222 (ChAdOx1-nCoV-19) Covid-19 vaccine in solid malignancy patients receiving cancer treatment, as compared to age-matched healthy cont...

por Pakvisal, Nussara, Sainamthip, Panot, Teeyapun, Nattaya, Luangdilok, Sutima, Wanlapakorn, Nassamon, Yorsaeng, Ritthideach, Poovorawan, Yong, Pakvisal, Piyapoom, Susiriwatananont, Thiti, Zungsontiporn, Nicha, Sriuranpong, Virote, Tanasanvimon, Suebpong, Wanchaijiraboon, Passakorn
Publicado 2022

Durability of Immune Response to ChAdOx1-nCoV-19 Vaccine in Solid Cancer Patients Undergoing Anticancer Treatment

por Wanchaijiraboon, Passakorn, Teeyapun, Nattaya, Pakvisal, Nussara, Sainamthip, Panot, Susiriwatananont, Thiti, Zungsontiporn, Nicha, Suntronwong, Nungruthai, Vichaiwattana, Preeyaporn, Klinsawat, Worata, Wanlapakorn, Nasamon, Tanasanvimon, Suebpong, Sriuranpong, Virote, Poovorawan, Yong, Luangdilok, Sutima
Publicado 2022

OP12 Durability and immunogenicity after two doses of ChAdOx1 nCov-19 among the type of cancer treatment in oncologic patients: A prospective, multicenter observational study

por Wanchaijiraboon, P., Teeyapun, N., Luangdilok, S., Wanlapakorn, N., Sainamthip, P., Pakvisal, N., Namkanisorn, T., Sriuranpong, V., Phaibulvatanapong, E., Veranitinun, R., Inthasuwan, P., Sartsuk, C., Phongwan, R., Angspatt, P., Wongchanapat, P., Poovorawan, Y., Tanasanvimon, S.
Publicado 2022

Expression of CC chemokine receptor 7 in tonsillar cancer predicts cervical nodal metastasis, systemic relapse and survival

por Pitkin, L, Luangdilok, S, Corbishley, C, Wilson, P O G, Dalton, P, Bray, D, Mady, S, Williamson, P, Odutoye, T, Rhys Evans, P, Syrigos, K N, Nutting, C M, Barbachano, Y, Eccles, S, Harrington, K J
Publicado 2007

Immunogenicity of ChAdOx1-nCoV-19 vaccine in solid malignancy patients by treatment regimen versus healthy controls: A prospective, multicenter observational study

por Teeyapun, Nattaya, Luangdilok, Sutima, Pakvisal, Nussara, Sainamthip, Panot, Mingmalairak, Siyamol, Poovorawan, Nattaya, Sitthideatphaiboon, Piyada, Parinyanitikul, Napa, Sriuranpong, Virote, Namkanisorn, Teerayuth, Inthasuwan, Pratchaya, Angspatt, Pattama, Wongchanapat, Ploytuangporn, Bamrungnam, Akradach, Leeleakpai, Nutchanok, Uttha, Sutheera, Jaichum, Supaporn, Kongkaew, Peerawich, Suksanong, Chayanin, Veranitinun, Rattiya, Prasomphol, Ampai, Sartsuk, Chada, Patcharajutanon, Cheeraporn, Preaprang, Supreeya, Choengsamor, Hathairat, Phongwan, Rungthong, Preeyasaksa, Charoenpit, Phaibulvatanapong, Ekkamol, Suntronwong, Nungruthai, Yorsaeng, Ritthideach, Vichaiwattana, Preeyaporn, Wanlapakorn, Nasamon, Kerr, Stephen J., Poovorawan, Yong, Wanchaijiraboon, Passakorn, Tanasanvimon, Suebpong
Publicado 2022